Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Emergence of a novel swine-origin influenza A (H1N1) virus in humans.

Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM.

N Engl J Med. 2009 Jun 18;360(25):2605-15. doi: 10.1056/NEJMoa0903810. Epub 2009 May 7. Erratum in: N Engl J Med. 2009 Jul 2;361(1):102.

2.

Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge.

Hamada H, Garcia-Hernandez Mde L, Reome JB, Misra SK, Strutt TM, McKinstry KK, Cooper AM, Swain SL, Dutton RW.

J Immunol. 2009 Mar 15;182(6):3469-81. doi: 10.4049/jimmunol.0801814.

3.

Global transmission of oseltamivir-resistant influenza.

Moscona A.

N Engl J Med. 2009 Mar 5;360(10):953-6. doi: 10.1056/NEJMp0900648. Epub 2009 Mar 2. No abstract available.

4.

Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus.

Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, Sabourin PJ, Long JP, García-Sastre A, Tolnay AE, Albrecht R, Pyles JA, Olson PH, Aicher LD, Rosenzweig ER, Murali-Krishna K, Clark EA, Kotur MS, Fornek JL, Proll S, Palermo RE, Sabourin CL, Katze MG.

Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3455-60. doi: 10.1073/pnas.0813234106. Epub 2009 Feb 13.

5.

The roles of IL-17A in inflammatory immune responses and host defense against pathogens.

Iwakura Y, Nakae S, Saijo S, Ishigame H.

Immunol Rev. 2008 Dec;226:57-79. doi: 10.1111/j.1600-065X.2008.00699.x. Review.

PMID:
19161416
6.

CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity.

Yamashita M, Tomozawa T, Kakuta M, Tokumitsu A, Nasu H, Kubo S.

Antimicrob Agents Chemother. 2009 Jan;53(1):186-92. doi: 10.1128/AAC.00333-08. Epub 2008 Oct 27.

7.

Basal cells of differentiated bronchial epithelium are more susceptible to rhinovirus infection.

Jakiela B, Brockman-Schneider R, Amineva S, Lee WM, Gern JE.

Am J Respir Cell Mol Biol. 2008 May;38(5):517-23. Epub 2007 Dec 6.

8.

Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus.

Kobasa D, Jones SM, Shinya K, Kash JC, Copps J, Ebihara H, Hatta Y, Kim JH, Halfmann P, Hatta M, Feldmann F, Alimonti JB, Fernando L, Li Y, Katze MG, Feldmann H, Kawaoka Y.

Nature. 2007 Jan 18;445(7125):319-23.

PMID:
17230189
9.

Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model.

Maines TR, Chen LM, Matsuoka Y, Chen H, Rowe T, Ortin J, Falcón A, Nguyen TH, Mai le Q, Sedyaningsih ER, Harun S, Tumpey TM, Donis RO, Cox NJ, Subbarao K, Katz JM.

Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):12121-6. Epub 2006 Jul 31.

10.

Architecture of ribonucleoprotein complexes in influenza A virus particles.

Noda T, Sagara H, Yen A, Takada A, Kida H, Cheng RH, Kawaoka Y.

Nature. 2006 Jan 26;439(7075):490-2.

PMID:
16437116
11.

Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor.

Hatakeyama S, Sakai-Tagawa Y, Kiso M, Goto H, Kawakami C, Mitamura K, Sugaya N, Suzuki Y, Kawaoka Y.

J Clin Microbiol. 2005 Aug;43(8):4139-46.

12.

Ebola virus VP40 late domains are not essential for viral replication in cell culture.

Neumann G, Ebihara H, Takada A, Noda T, Kobasa D, Jasenosky LD, Watanabe S, Kim JH, Feldmann H, Kawaoka Y.

J Virol. 2005 Aug;79(16):10300-7.

13.

Resistant influenza A viruses in children treated with oseltamivir: descriptive study.

Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, Kimura K, Hayden FG, Sugaya N, Kawaoka Y.

Lancet. 2004 Aug 28-Sep 3;364(9436):759-65.

PMID:
15337401
14.

Re-emergence of fatal human influenza A subtype H5N1 disease.

Peiris JS, Yu WC, Leung CW, Cheung CY, Ng WF, Nicholls JM, Ng TK, Chan KH, Lai ST, Lim WL, Yuen KY, Guan Y.

Lancet. 2004 Feb 21;363(9409):617-9.

PMID:
14987888
15.

In vitro and in vivo activities of anti-influenza virus compound T-705.

Furuta Y, Takahashi K, Fukuda Y, Kuno M, Kamiyama T, Kozaki K, Nomura N, Egawa H, Minami S, Watanabe Y, Narita H, Shiraki K.

Antimicrob Agents Chemother. 2002 Apr;46(4):977-81.

16.

Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses.

Hatta M, Gao P, Halfmann P, Kawaoka Y.

Science. 2001 Sep 7;293(5536):1840-2.

17.

Pathogenesis of influenza A (H5N1) virus infection in a primate model.

Rimmelzwaan GF, Kuiken T, van Amerongen G, Bestebroer TM, Fouchier RA, Osterhaus AD.

J Virol. 2001 Jul;75(14):6687-91.

18.

Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group.

Hayden FG, Gubareva LV, Monto AS, Klein TC, Elliot MJ, Hammond JM, Sharp SJ, Ossi MJ; Zanamivir Family Study Group.

N Engl J Med. 2000 Nov 2;343(18):1282-9.

19.
20.

Recent human influenza A (H1N1) viruses are closely related genetically to strains isolated in 1950.

Nakajima K, Desselberger U, Palese P.

Nature. 1978 Jul 27;274(5669):334-9.

PMID:
672956

Supplemental Content

Support Center